In short
This article discusses a Phase IV clinical trial investigating the safety of Almagate, an antacid medication, in pregnant women experiencing heartburn and reflux. The study aims to assess the effects of Almagate on both the mother and the developing fetus, as well as perinatal outcomes in newborns. This multicenter, open-label, single-arm study will provide valuable insights into the use of Almagate during pregnancy and its potential impact on maternal and fetal health.
At a glance
- Study Type
- Phase IV, multicenter, open-label, single-arm
- Participants
- Pregnant women aged 18-45 with heartburn
- Main Objective
- Assess safety of Almagate in pregnant women and perinatal outcomes
- Secondary Objectives
- Evaluate efficacy of Almagate, assess patient satisfaction, monitor newborn development
- Duration
- Estimated 36 months (including 24-month follow-up of newborns)
- Key Outcomes
- Gestational diabetes, hypertensive states, perinatal mortality, maternal mortality, low birth weight
- Exclusion Criteria
- First trimester pregnancy, high-risk pregnancy, previous antacid use during current pregnancy
What is ALMAGATE?
ALMAGATE is a medication primarily used to treat heartburn and reflux, particularly in pregnant women. It belongs to a class of drugs known as antacids, which help neutralize stomach acid. The brand name for ALMAGATE is Almax Forte, and it comes in the form of an oral suspension (a liquid medication that you drink).
Medical Conditions Treated
ALMAGATE is specifically designed to treat:
- Heartburn: A burning sensation in the chest often caused by stomach acid flowing back into the esophagus.
- Reflux: Also known as acid reflux or gastroesophageal reflux disease (GERD), where stomach contents flow back into the esophagus, causing discomfort and potential damage.
Safety in Pregnancy
One of the key features of ALMAGATE is its potential safety for use during pregnancy. A clinical study is currently being conducted to evaluate the safety of ALMAGATE in pregnant women with heartburn and reflux, as well as its effects on the developing fetus and newborn. This study focuses on women in their second and third trimesters of pregnancy.
How ALMAGATE Works
ALMAGATE works by neutralizing excess stomach acid. This helps to relieve the symptoms of heartburn and reflux, providing comfort to those experiencing these conditions.
Dosage and Administration
ALMAGATE is taken orally as a suspension. The maximum daily dose is 8 grams, and the maximum total dose over a treatment period is 112 grams. The typical treatment period lasts up to 14 days. However, always follow your doctor's instructions regarding dosage and duration of treatment.
Effectiveness
The ongoing clinical study aims to evaluate the efficacy of ALMAGATE in reducing heartburn and reflux in pregnant women. Patients and physicians will assess the effectiveness of the medication after each episode of heartburn or reflux, rating it from "very poor" to "very good".
Potential Side Effects
While the current study is specifically looking at the safety profile of ALMAGATE, it's important to note that all medications can have potential side effects. The study is monitoring various outcomes, including:
- Gestational diabetes
- Hypertensive states of pregnancy
- Complications during delivery
- Effects on the newborn, including birth weight and development
Who Should Not Use ALMAGATE
Based on the exclusion criteria of the ongoing study, ALMAGATE may not be suitable for pregnant women who:
- Are in their first trimester of pregnancy
- Have a high-risk pregnancy
- Have been diagnosed with Alzheimer's disease
- Have high blood pressure
- Have diabetes mellitus
- Have undiagnosed gastrointestinal or rectal bleeding
- Are hypersensitive to ALMAGATE or any of its ingredients
Ongoing Research
A Phase IV clinical trial is currently underway to further evaluate the safety and efficacy of ALMAGATE in pregnant women. This study will follow participants through their pregnancy and monitor the development of their children up to 24 months of age. The research aims to provide more comprehensive data on the use of ALMAGATE during pregnancy and its potential effects on both mother and child.